Los fibratos en la prevención secundaria de la enfermedad cardiovascular (infarto e ictus). Resultados de una revisión sistemática y metaanálisis de la colaboración Cochrane-Reference-Cited by-同舟云学术

Los fibratos en la prevención secundaria de la enfermedad cardiovascular (infarto e ictus). Resultados de una revisión sistemática y metaanálisis de la colaboración Cochrane

Published:2018-01 Issue:1 Volume:30 Page:30-35
ISSN:0214-9168
Container-title:Clínica e Investigación en Arteriosclerosis
language:es
Short-container-title:Clínica e Investigación en Arteriosclerosis

Author:

Millan Jesus,Pintó Xavier,Brea Angel,Blasco Mariano,Hernández-Mijares Antonio,Ascaso Juan,Diaz Angel,Mantilla Teresa,Pedro-Botet Juan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Fibrates for secondary prevention of cardiovascular disease and stroke;Wang;Cochrane Database Syst Rev.,2015

2. Lipids and risk of coronary heart disease. The Framingham Study;Castelli;Ann Epidemiol.,1992

3. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study;Gordon;Am J Med.,1977

4. Triglycerides and cardiovascular disease;Nordestgaard;Lancet.,2014

5. The use of fibric acid derivatives in cardiovascular prevention;Khoury;Curr Treat Options Cardiovasc Med.,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments;Cureus;2024-06-24

2. Dyslipidemia: A Narrative Review on Pharmacotherapy;Pharmaceuticals;2024-02-23

3. Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis;Clínica e Investigación en Arteriosclerosis;2023-07

4. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease;Medicinal Research Reviews;2023-04-29

5. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies;Frontiers in Cardiovascular Medicine;2022-02-10